Forest Laboratories competitors

Zippia score 4.8

Forest Laboratories main competitors are Novartis, Salix Pharmaceuticals, and Gilead Sciences.

Competitor Summary. See how Forest Laboratories compares to its main competitors:

Johnson & Johnson has the most employees (134,500).
Employees at Novartis earn more than most of the competitors, with an average yearly salary of $112,479.
The oldest company is Wyeth Biopharma, founded in 1860.

Work at Forest Laboratories?

Share your experience

Forest Laboratories vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Forest Laboratories	1954	4.8	New York, NY	1	$3.6B	6,200
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
Johnson & Johnson	1886	4.7	New Brunswick, NJ	26	$88.8B	134,500
Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$11.0B	3,400
Salix Pharmaceuticals	1989	4.2	Raleigh, NC	2	$1.1B	1,000
Amgen	1980	4.8	Thousand Oaks, CA	9	$33.4B	22,000
Gilead Sciences	1987	4.5	Foster City, CA	9	$28.8B	11,800
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Seagen	1997	4.7	Bothell, WA	3	$2.0B	900
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Otsuka Pharmaceuticals	1989	4.9	Rockville, MD	3	$4.4B	7,500
Forest Pharmaceuticals Inc	1954	4.2	Saint Louis, MO	1	$40.0M	50
Allergan plc	1948	4.8	Irvine, CA	1	$7.2B	11,400
Novartis	1996	4.9	East Hanover, NJ	16	$51.7B	110,000
Wyeth Biopharma	1860	4.7	Madison, NJ	1	$22.4B	49,732
SmithKline Beecham Holdings Corporation	1996	4.3	Wilmington, DE	1	-	1,500
Eisai	1995	4.8	Woodcliff Lake, NJ	2	$5.3B	1,864
Biopharma	1896	4.1	-	-	$200,000	500
Shire Pharmaceuticals Inc	2004	4.9	Wayne, PA	1	$15.2B	3,500
Roche Diagnostics Middle East	2012	4.5	-	-	$53.0M	635
Purdue Pharma L.P.	1892	4.9	Stamford, CT	2	$3.0B	5,000

Rate Forest Laboratories' competitiveness in the market.

Forest Laboratories salaries vs competitors

Among Forest Laboratories competitors, employees at Novartis earn the most with an average yearly salary of $112,479.

Compare Forest Laboratories salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Forest Laboratories	$91,901	$44.18	-
Merck	$90,328	$43.43	-
Johnson & Johnson	$76,686	$36.87	-
Vertex Pharmaceuticals	$95,952	$46.13	-
Salix Pharmaceuticals	$106,558	$51.23	-
Amgen	$93,349	$44.88	-

Compare Forest Laboratories job title salaries vs competitors

Company	Highest salary	Hourly salary
Forest Laboratories	$149,709	$71.98
Allergan plc	$151,709	$72.94
Regeneron	$149,503	$71.88
Salix Pharmaceuticals	$148,897	$71.58
Amgen	$148,853	$71.56
Vertex Pharmaceuticals	$148,498	$71.39
Novartis	$148,142	$71.22
Sanofi Genzyme	$147,468	$70.90
Merck	$144,655	$69.55
Forest Pharmaceuticals Inc	$144,263	$69.36
Wyeth Biopharma	$142,764	$68.64
Seagen	$140,788	$67.69
Gilead Sciences	$140,759	$67.67
Eisai	$140,584	$67.59
SmithKline Beecham Holdings Corporation	$136,946	$65.84
Roche Diagnostics Middle East	$136,717	$65.73
Purdue Pharma L.P.	$136,151	$65.46
Johnson & Johnson	$132,934	$63.91
Otsuka Pharmaceuticals	$130,018	$62.51
Shire Pharmaceuticals Inc	$128,835	$61.94

Do you work at Forest Laboratories?

Does Forest Laboratories effectively differentiate itself from competitors?

Forest Laboratories jobs

Forest Laboratories demographics vs competitors

Compare gender at Forest Laboratories vs competitors

Job title	Male	Female
Merck	54%	46%
Regeneron	54%	46%
Gilead Sciences	56%	44%
Amgen	57%	43%
Johnson & Johnson	58%	42%
Forest Laboratories	-	-

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Forest Laboratories vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Amgen	49%	24%	7%	15%	5%	9.7
Gilead Sciences	44%	20%	8%	23%	6%	9.8
Johnson & Johnson	54%	16%	10%	15%	4%	9.8
Merck	56%	16%	10%	14%	4%	9.8
Regeneron	54%	15%	10%	17%	4%	9.8
Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7

Forest Laboratories revenue vs competitors

Forest Laboratories revenue is $3.6B. Among it's competitors, the company with the highest revenue is Johnson & Johnson, $88.8B . The company with the lowest revenue is Biopharma, $200.0K.

Forest Laboratories and similar companies CEOs

CEOBio

Robert A. Bradway

Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Daniel O’Day

Gilead Sciences

Joaquin Duato

Johnson & Johnson

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Roger D. Dansey

Seagen

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Haruo Naito

Eisai

Haruo Naito is a Board Member at Eisai. He has worked as Director at Eisai, President/CEO at Eisai, and Executive Vice President at Eisai. Haruo works or has worked as CHAIRMAN at The Naiito Foundation. He attended Keio University and Northwestern University.

Paul Hudson

Sanofi Genzyme

Vasant Narasimhan

Novartis

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis (since 2018).

Dr. William Carson H.

Otsuka Pharmaceuticals

Dr. William Carson H. is a President and Chief Executive Officer at Otsuka America Pharmaceutical, Inc. and is based in United States.